CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops 3D-printed titanium implants with bioactive materials to enhance bone regeneration after tumor resection. By optimizing implant design and testing for biocompatibility, the project aims to improve recovery outcomes for patients undergoing orthopedic surgeries for bone cancer.
Osteosarcoma and Ewing sarcoma are the most common types of cancer in patients younger than 30 years.
The gold standard treatment is bone tumor resection followed by reconstruction of the tissue, thereby allowing the salvage of the limb.
Titanium and its alloys are mostly used in such orthopedic surgeries due to their biocompatibility and excellent mechanical properties. A novel, cutting-edge technology of patient-specific implants, 3-dimensional (3D) printed porous titanium implants, was recent…
TEL AVIV UNIVERSITY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, ROMA RM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
